EXAMINE THIS REPORT ON TRASTUZUMAB MONITORING

Gastric cancer, metastatic: Treatment method of HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma (in combination with cisplatin and both capecitabine or five-fluorouracil) in clients who definitely have not received prior treatment for metastatic disease.Trastuzumab works by binding to HER2, a protein present in su